OptiNose today announced that the company will present at the 33rd annual J.P. Morgan Healthcare Conference. CEO Peter Miller will discuss the Company’s recent milestones, pipeline and strategy for 2015.
“Our bi-directional Breath Powered technology has the potential to improve treatment for patients across a wide range of underserved disease states, as evidenced by the success we have seen to date in clinical trials for our OPN-375 product to treat chronic nasal inflammatory diseases,” Miller stated.
Help employers find you! Check out all the jobs and post your resume.
